SRI Official Discusses Pharmaceutical Development

From: Public Affairs

HARRISONBURG—How long does it take to develop a drug? What drives the cost in drug discovery and development? How does the ever-changing environment of drug discovery operate successfully? Walter Moos, vice president of the biosciences division of SRI International, will have the answers when he speaks at 5 p.m. Tuesday, Oct. 23 at James Madison University.

Moos' presentation, which is free and open to the public, will be held in Room 2301 of the Health and Human Services Building on the JMU campus east of Interstate 81. Parking will be available in Lot D-2 across from the building. Click here for a map.

SRI International is one of the world's largest independent nonprofit research and development organizations, originally founded as the Stanford Research Institute in 1946. In December, SRI announced plans to build offices in Rockingham County and partner with JMU and other Virginia institutions to open its new Center for Advanced Drug Research (CADRE). The new center will create more than 100 new jobs in state-of-the-art pharmaceutical research. Until its new offices are completed, SRI employees are operating out of JMU facilities.

Prior to his service at SRI, Moos served as chairman and chief executive officer of MitoKor (now Migenix) and as vice president of research and development in the technologies division of Chiron (now Novartis). Moos holds a doctorate in chemistry from the University of California, Berkeley, and received a bachelor's degree in chemistry from Harvard University. He has held adjunct faculty positions at the University of Michigan, Ann Arbor, and since 1992 has been an adjunct professor at the University of California, San Francisco.

Moos' talk is sponsored by the JMU student chapter of the Virginia Biotechnology Association and the JMU Tri-Beta Biological Honor Society.

For more information, contact Eric Gorton at 540-568-3674 or gortonej@jmu.edu.

###